For the latest updates on Gilead’s ongoing response to COVID-19, please click here.

Find a Treatment Center

Investor Relations

Contact Us

KiteKonnect®

Press Releases

Filter By Year

2022

May 17, 2022
Gilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting

April 19, 2022
Kite Receives U.S. FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland
April 01, 2022
Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma (LBCL)

January 31, 2022
U.S. FDA Approves New Label Update for CAR T-Cell Therapy Yescarta® Showing Prophylactic Steroid Use Improves Management of Cytokine Release Syndrome

Filter By Year